CA
IMGN

CoreCap Advisors’s Immunogen Inc IMGN Stock Holding History

CoreCap Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$332 Buy
+67
New +$363 ﹤0.01% 2219
2022
Q3 		– Sell
-67
Closed – – 2238
2022
Q2 		$0 Buy
+67
New +$291 ﹤0.01% 2319

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CoreCap Advisors's IMGN Position: Q4 2022 in Review

CoreCap Advisors opened a new position in Immunogen Inc (IMGN) in Q4 2022: 67 shares worth $332. The stake represents ﹤0.01% of the portfolio and ranks #2219 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in IMGN as recently as Q2 2022.

CoreCap Advisors first reported a position in IMGN in Q2 2022 and has held it in 2 quarters since. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • CoreCap Advisors held 67 shares of Immunogen Inc worth $332 as of Q4 2022.
  • Immunogen Inc was a new CoreCap Advisors position in Q4 2022.
  • Immunogen Inc made up ﹤0.01% of CoreCap Advisors's portfolio in Q4 2022, its #2219 holding.
  • CoreCap Advisors first reported a position in Immunogen Inc in Q2 2022 and has held it in 2 quarters since.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on CoreCap Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.